{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:52:12Z","timestamp":1781686332539,"version":"3.54.5"},"reference-count":8,"publisher":"Norwegian Medical Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.20.0371","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T13:45:37Z","timestamp":1610459137000},"source":"Crossref","is-referenced-by-count":0,"title":["A man in his seventies with dyspnoea and ataxia after BCG instillation for bladder cancer"],"prefix":"10.4045","volume":"141","author":[{"given":"Christine Krohn","family":"Steenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bredberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnhild","family":"Eiken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Jacoiste As\u00edn\u00a0MA, Fern\u00e1ndez-Ruiz\u00a0M, L\u00f3pez-Medrano\u00a0F et al. Bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine (Baltimore) 2014; 93: 236\u201354. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25398060&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097%2FMD.0000000000000119","DOI":"10.1097\/MD.0000000000000119"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Barza\u00a0MJ, Blum\u00a0JH, Graeme-Cook\u00a0FM. Case 29-1998. A 57-year-old man with fever and jaundice after intravesical instillation of bacille Calmette-Gu\u00e9rin for bladder cancer. N Engl J Med 1998; 339: 831\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9750077&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJM199809173391209","DOI":"10.1056\/NEJM199809173391209"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Lamm\u00a0DL. Efficacy and safety of bacille Calmette-Gu\u00e9rin immunotherapy in superficial bladder cancer. Clin Infect Dis 2000; 31 (suppl 3): S86\u201390. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11010830&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1086%2F314064","DOI":"10.1086\/314064"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Durek\u00a0C, Richter\u00a0E, Basteck\u00a0A et al. The fate of bacillus Calmette-Guerin after intravesical instillation. J Urol 2001; 165: 1765\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11342972&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0022-5347(05)66410-5","DOI":"10.1016\/S0022-5347(05)66410-5"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Mack\u00a0D, Frick\u00a0J. Low-dose bacille Calmette-Gu\u00e9rin (BCG) therapy in superficial high-risk bladder cancer: a phase II study with the BCG strain Connaught Canada. Br J Urol 1995; 75: 185\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7850323&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1464-410X.1995.tb07308.x","DOI":"10.1111\/j.1464-410X.1995.tb07308.x"},{"key":"ref=6","unstructured":"Lie\u00a0IA, Blomberg\u00a0B, Power\u00a0\u00d8A et al. Mann i 20-\u00e5rene med svimmelhet, dobbeltsyn og perifer facialisparese. Tidsskr Nor Legeforen 2018; 138. doi: 10.4045\/tidsskr.17.0801. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30277051&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4045%2Ftidsskr.17.0801"},{"key":"ref=7","unstructured":"Helsedirektoratet. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppf\u00f8lging av bl\u00e6re- og urotelkreft.\u00a0https:\/\/www.helsebiblioteket.no\/retningslinjer\/bl\u00e6rekreft\/initial-behandling-og-behandling-av-nmibc\/instillasjon-av-bcg-i-bl\u00e6re Appendiks: https:\/\/www.helsebiblioteket.no\/retningslinjer\/bl\u00e6rekreft\/appendiks\/behandlingsskjema-bcg Lest 20.4.2020."},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Hauser\u00a0WE, Remington\u00a0JS. Effect of antibiotics on the immune response. Am J Med 1982; 72: 711\u20136. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7044118&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2F0002-9343(82)90534-4","DOI":"10.1016\/0002-9343(82)90534-4"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Mann i 70-\u00e5rene med tungpust og ataksi etter BCG-instillasjon mot bl\u00e6rekreft"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:57:15Z","timestamp":1781683035000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2020\/12\/noe-laere-av\/mann-i-70-arene-med-tungpust-og-ataksi-etter-bcg-instillasjon-mot-blaerekreft"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,12]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.20.0371","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]}}}